Ads
related to: Abbvie- About Multiple Myeloma
Learn More About Treatments At
First Relapse For Your Patients.
- Efficacy Information
Review Clinical Data, Results,
Study Overviews, And More.
- Access & Reimbursement
Find Support, Tools, And Resources
For HCPs, Caregivers And Patients.
- HCP FAQs
Discover Answers To Commonly Asked
Questions At The Official HCP Site.
- Connect With A Rep
Contact A Field Representative For
Questions Or To Schedule A Visit.
- Safety Information
View Safety Profiles For
A Combination Treatment.
- About Multiple Myeloma
Search results
AbbVie Inc. (NYSE:ABBV) Shares Sold by Ritholtz Wealth Management
ETF DAILY NEWS· 6 hours agoRitholtz Wealth Management lessened its stake in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 9.9% during the fourth quarter, according to the company in its most recent ...
Ballast Inc. Has $482,000 Stock Holdings in AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 6 hours agoBallast Inc. boosted its holdings in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 77.3% in the fourth quarter, according to its most recent filing with the SEC. The ...
AbbVie (NYSE:ABBV) Trading Up 0.1% Following Analyst Upgrade
ETF DAILY NEWS· 10 hours agoAbbVie Inc. (NYSE:ABBV – Get Free Report) shot up 0.1% on Wednesday after Barclays raised their price target on the stock from $185.00 to $195.00. AbbVie
AbbVie (NYSE:ABBV) PT Raised to $195.00 at Barclays
ETF DAILY NEWS· 10 hours agoAbbVie (NYSE:ABBV – Get Free Report) had its price target increased by research analysts at Barclays from $185.00 to $195.00 in a research report issued on Wednesday, MarketBeat ...
AbbVie: An Undervalued Giant
GuruFocus.com via Yahoo Finance· 2 days agoAbbVie Inc. (NYSE:ABBV) has made a decent recovery this year, jumping 11%. However, no good deed goes unpunished on Wall Street, so it still represents...
Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know
Zacks via Yahoo Finance· 4 days agoAbbVie (ABBV) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good...
Aldeyra stock gains on plans for AbbVie-partnered drug
Seeking Alpha· 19 hours agoAldeyra Therapeutics (ALDX) stock gains as company plans to resubmit a marketing application for its...
AbbVie (ABBV) to Buy Landos to Strengthen Autoimmune Portfolio
Zacks via Yahoo Finance· 3 days agoAbbVie ABBV announced a definitive agreement to acquire Landos Biopharma LABP, which makes novel,...
Pharma Stock Roundup: ABBV & NVO's New M&As, FDA Nod to JNJ & MRK PAH Drugs
Zacks via Yahoo Finance· 23 hours agoWhile AbbVie (ABBV) is set to buy Landos Biopharma, Novo Nordisk (NVO) is set to acquire Cardior...
Taking a look at what insiders are doing to gauge the Abbvie Inc [ABBV]’s direction – Knox Daily
Knox Daily· 1 day agoInvestors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Abbvie Inc shares valued at $3,716,757 were sold by Donoghoe Nicholas ...
Ads
related to: Abbvie